Search


Current filters:


Clear current filters  or Add more filters

View Option



Results 1-10 of 11 (Search time: 0.004 seconds).

  Metronomic oral vinorelbine (MOVIN): a dose establishing translational and pharmacokinetic study in patients with metastatic refractory cancer (Journal article)

  Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma (Journal article)

  Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas (Journal article)

  Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP (Journal article)

  Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials (Journal article)

  The effect of the aromatase inhibitor letrozole on lipid parameters in postmenopausal women with metastatic breast cancer. A preliminary report. (Journal article)

  Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes? (Journal article)

  Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group (Journal article)

  Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer (Journal article)

  Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study (Journal article)